Natural killer cells and their receptors

Transplant Immunology

Volumn 10, Issue 2-3, 2002, Pages 147-164

  Middleton, Derek ^a,b,c   Curran, Martin ^a,c   Maxwell, Lynne ^a,c  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

CD94 NKG2 killer lectin like receptor; Detection and frequency of KIR genes; HLA ligand; Killer inhibitory receptor; Missing self hypothesis; Natural killer cell

Indexed keywords

CD56 ANTIGEN; CD94 ANTIGEN; CELL RECEPTOR; HLA ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN RECEPTOR; KILLER INHIBITORY RECEPTOR; KILLER LECTIN LIKE RECEPTOR; LIGAND; NATURAL CYTOTOXIC RECEPTOR; UNCLASSIFIED DRUG;

ALLELE; AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; EVOLUTION; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNE SYSTEM; INFECTION CONTROL; LYSIS; NATURAL KILLER CELL; ORGAN TRANSPLANTATION; PREGNANCY; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; VIRUS INFECTION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD94; AUTOIMMUNE DISEASES; CHROMOSOMES, HUMAN, PAIR 19; CYTOTOXICITY, IMMUNOLOGIC; EVOLUTION, MOLECULAR; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MODELS, MOLECULAR; PREGNANCY; PROTEIN CONFORMATION; RECEPTORS, IMMUNOLOGIC; TRANSPLANTATION IMMUNOLOGY;

EID: 0036347955     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(02)00062-X     Document Type: Review

References (128)

1. Biology of natural killer cells
2. Natural killer cells and natural killer T cells
3. The cytokine profile of resting and activated NK cells
4. Association between natural killer cell activity and infection in immunologically normal elderly people
5. In search of the missing self: MHC molecules and NK recognition
6. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules
7. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors
8. Identification of a human member of the Ly-49 multigene family
9. Divergent and convergent evolution of NK-cell receptors
10. The human leukocyte antigen (HLA)-C specific 'activatory' or 'inhibitory' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions
11. Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR103
12. Genes encoding human killer-cell Ig-like receptors with D1 and D2 extracellular domains all contain untranslated pseudoexons encoding a third Ig-like domain
13. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells
14. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities
15. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by 'group 2' or 'group 1' NK clones
16. NK cell receptor gene of the KIR family with two Ig domains but highest homology to KIR receptors with three Ig domains
17. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells
18. NKB1: A natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules
19. A human killer inhibitory receptor specific for HLA-A
20. The natural killer cell receptor specific for HLA-A allotypes: A novel member of the p58/p70 family of inhibitory receptors that is characterised by 3 immunoglobulin domains and is expressed as a 140 kDa disulphide linked dimer
21. KIR2DL5, a novel killer-cell receptor with a D0 D2 configuration of immunoglobulin like domains
22. Killer-cell immunoglobulin-like receptor gene haplotypes contain between zero and two KIR2DL5 loci
23. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand
24. Peptide specificity in the recognition of MHC class I by natural killer cell clones
25. Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells
26. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity
27. NK cell receptors
28. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes
29. Human diversity in killer cell inhibitory receptor genes
30. Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires
31. Allele resolution of HLA-A using oligonucleotide probes in a two stage typing strategy
32. Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination
33. Determination of KIR haplotypes in CEPH
34. Detection of KIR2DL4 alleles by sequencing and SSCP reveals a common allele with a shortened cytoplasmic tail
35. Frequency of HLA-B alleles in a Caucasoid population determined by a two-stage PCR-SSOP typing strategy
36. Evidence for recombination as a mechanism for KIR diversification
37. Identification of seventeen novel KIR variants: Fourteen of them from two non-Caucasian donors
38. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotypes
39. Molecular characterization of human CD94: A type II membrane glycoprotein related to the C-type lectin superfamily
40. Human NK cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits
41. NKG2A complexed with CD94 defines a novel inhibitory NK cell receptor
42. The CD94 and NKG2-AC type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules
43. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells
44. A multigene family on human chromosome 12 encodes natural killer-cell lectins
45. Natural killer lectin-like receptors have divergent carboxy-termini, distinct from C-type lectins
46. Cloning of NKG2-F, a new member of the NKG2 family of human natural killer cell receptor genes
47. Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer
48. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
49. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
50. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences
51. Structural features impose tight peptide binding specificity in the non-classical MHC molecule HLA-E
52. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
53. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
54. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E
55. Natural killer cell recognition of HLA class I molecules
56. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand
57. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes
58. Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis
59. An activating immunoreceptor complex formed by NKG2D and DAP-10
60. Identification of novel single nucleotide substitutions in the NKp30 gene expressed in human natural killer cells
61. 2B4 functions as a coreceptor in human natural killer cell activation
62. Identification of NKp80 a novel triggering molecule expressed by human natural killer cells
63. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C
64. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor
65. The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function
66. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
67. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition
68. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: Evidence for receptor function in heterologous transfectants
69. Association of DAP12 with activating CD94/NKG2C NK cell receptors
70. Natural killer cell cytolytic activity is inhibited by NKG2a and activated by NKG2c
71. Plasticity in the organization and sequences of human KIR/ILT gene families
72. Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans
73. Genetic and functional relationships between MHC and NK receptor genes
74. DNA hybridization evidence of hominoid phylogeny: A reanalysis of the data
75. The NKB1 and HP-3E4 NK cell receptors are structurally distinct glycoproteins and independently recognise polymorphic HLA-B and HLA-C molecules
76. Killer cell receptors: Keeping pace with MHC class I evolution
77. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed function surface molecules: Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition
78. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors
79. Paired inhibitory and activating receptor signals
80. Human natural killer cell receptors and co-receptors
81. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
82. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human natural killer cells, Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells
83. Arousal and inhibition of human NK cells
84. Specificity of HLA class I antigen recognition by human NK clones: Evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type
85. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes
86. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human natural killer cells
87. Identification and characterization of a novel Siglec, Siglec-7, expressed by human natural killer cells and monocytes
88. Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer cell inhibitory receptors
89. Hybrid resistance: 'Negative' and 'positive' signalling of murine natural killer cells
90. Natural killer cells and their role in graft rejection
91. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice
92. Molecular typing shows a high level of HLA class I incompatibility in serologically well matched donor/patient pairs: Implications for unrelated bone marrow donor selection
93. HLA-C disparity between patients and unrelated donors matched for HLA-A, -B and -RB1 alleles: Impact of serological vs. DNA typing for HLA-A and -B loci
94. HLA-C mismatches induce strong cytotoxic T-cell reactivity in the presence of an additional DRB/DQB mismatch and affect NK cell-mediated alloreactivity
95. Matching for the HLA-Cw KIR ligand motif and DPA1 are associated with increased survival in unrelated stem cell transplantation
96. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation
97. Innate immune responses to transplants: A significant variable with cadaver donors
98. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytoxicity mediated by a subset of human NK cells
99. Viruses, host responses, and autoimmunity
100. Natural killer cells determine the outcome of B cell-mediated autoimmunity
101. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells
102. Anti-asialo GM1 antibody suppression of cyclophosphamide-induced diabetes in NOD mice
103. Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA)
104. Identification of natural killer cell receptor genotypes associated with leukaemia
105. Role of NK cell receptors in susceptibility to rheumatoid arthritis
106. X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of NK cells to kill EBV-infected cells
107. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts
108. Human uterine lymphocytes
109. Absence of natural killer cells during murine pregnancy is associated with reproductive compromise in Tge26 mice
110. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts
111. Evidence for the expression of HLAA-C class I mRNA and protein by human first trimester trophoblast
112. Viruses use stealth technology to escape from the host immune system
113. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells
114. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo
115. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
116. Cytomegalovirus evasion of the human cytotoxic T cell response by interaction of viral UL18 class I-like ligand and host ILT2/LIR1 receptor
117. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells
118. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40
119. Cutting edge: The human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis
120. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP
121. Receptors for HLA class-I molecules in human natural killer cells
122. Superantigen-dependent, cell-mediated cytoxicity inhibited by MHC class I receptors on T lymphocytes
123. Inhibition of ?d T-cell recognition by receptors for MHC class I molecules
124. Human CD8+ T lymphocyte subsets that express HLA-class I specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations
125. Role of NK1.1+T cells in a TH2 response and in immunologlobulin E production
126. T cells: A safety mechanism that may impair protective T-cell responses
127. Innate immunity and autoimmunity: From self-protection to self-destruction
128. Nucleotide and amino acid sequence alignment for human killer cell inhibitory receptors (KIR)